1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsProgramme de Recherche en Santé Publique - PRSP is sponsored by Agence Nationale de la Recherche (ANR) France. Aims to promote multidisciplinary research that will contribute significantly to the production of new knowledge or operational applications in public health.
Get alerted about grants like this
Save a search for “Agence Nationale de la Recherche (ANR) France” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Programme de Recherche en Santé Publique - PRSP | ANR Programme de Recherche en Santé Publique - PRSP Consultez la liste des projets financés ainsi que leurs résumés Funded projects presentation L'Agence Nationale de la Recherche lance un appel à projets (AAP) thématique dans le domaine de la santé publique.
Cet AAP vise à favoriser les recherches multidisciplinaires qui contribueront de manière significative à la production de connaissances nouvelles ou à des applications opérationnelles en santé publique.
Les projets pourront s'inscrire dans un ou plusieurs des axes thématiques suivants : Etudes des déterminants et des interactions entre les déterminants de santé et du maintien de l'autonomie Recherches de nature méthodologique Recherches sur les processus et indicateurs d'évaluation Recherches sur les systèmes d'information Aide à la soumission de projet, format HTML zippé Aide à la soumission de projet, format PDF Attestation de labellisation pôle de compétitivité Fiche d'évaluation expert Texte de l'appel à projets Date limite de soumission des projets sous forme électronique (document de soumission et chargement du document scientifique) : 24 novembre 2009 impérativement avant 13h00 .
sur le site de soumission En raison du nombre important de connexions sur le site de soumission , il est recommandé de procéder au renseignement des informations demandées sans attendre la date limite de dépôt des dossiers .
Date limite d'envoi du document de soumission sous forme papier, signé de tous les partenaires : 1er décembre 2009 à 24h (*), cachet de la poste faisant foi, à l'adresse ci dessous Pour tout renseignement, veuillez contacter, de préférence par courrier électronique : Claire Herzog ; claire. herzog@agencerecherche. fr , tel.
01 78 09 80 88 * : la date limite d'envoi du document de soumission sous forme papier est bien le 1er décembre 2009 comme indiqué dans le texte de l'appel à projets, et non le 24 novembre comme indiqué sur le site de soumission. List of selected projects "PROGRAMME DE RECHERCHE EN SANTE PUBLIQUE" Portail appelsprojetsrecherche.
fr Welcome to the French National Your browser is blocking third-party content, we have taken your choice into account. Continue without accepting
Based on current listing details, eligibility includes: Multidisciplinary research teams. Open to various research organizations. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Bilateral cooperation ANR – JST CREST 2026 for two research areas: "Symbiotic AI Interdisciplinary System" and "Prediction Mathematical Foundation" is sponsored by Agence Nationale de la Recherche (ANR) France. This call invites French teams to participate in collaborative research projects with Japanese teams on two priority research areas: 'Symbiotic AI Interdisciplinary System' and 'Prediction Mathematical Foundation'.
ANR-NRF Joint Call on AI in Biotechnology is sponsored by Agence Nationale de la Recherche (ANR) France and National Research Foundation of Korea (NRF). Promotes collaboration between French and Korean academic researchers to explore and develop AI applications in biotechnology, including bioinformatics, genomics, personalized medicine, precision agriculture, and drug discovery.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.